Live Breaking News & Updates on Large Scale Monoclonal Antibody Commercial Supply

Stay updated with breaking news from Large scale monoclonal antibody commercial supply. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EQS-Adhoc: Lonza Group AG: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply

EQS-Adhoc: Lonza Group AG: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply
Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply
16-Jul-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug conjugate (ADC) for use against hard-to-treat cancers
The deal enables the customer to access commercial-scale production of all elements of its ADC at one site, ensuring security of supply and delivering significant economies of scale. It demonstrates the value of Lonza s Ibex ....

Switzerland General , Dirk Oehlers , Jean Christophe Hyvert , Charles Christy , Head Of External Communications , Lonza Group Ltd , Agreement Development Of Sales , Hr Solutions , Lonza Group , Eqs Group , Swiss Exchange , Lonza Group Ag Key , Group News Service , Extends Collaboration , Major Biopharmaceutical Partner , Large Scale Monoclonal Antibody Commercial Supply , Christophe Hyvert , Gene Divisions , Commercial Solutions , Swiss Alps , சார்லஸ் கிறிஸ்டி , தலை ஆஃப் வெளிப்புறம் தகவல்தொடர்புகள் , ர் தீர்வுகள் , ஈக்ஸ் குழு , சுவிஸ் பரிமாற்றம் , குழு செய்தி சேவை ,

EQS-Adhoc: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply

EQS-Adhoc: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply
vom 16.07.2021, 07:00 Uhr
Bild: pixabay.com
Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply
16-Jul-2021 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug conjugate (ADC) for use against hard-to-treat cancers
The deal enables the customer to access commercial-scale production of all elements of its ADC at one site, ensuring security of supply and delivering significant economies of scale. It demonstrates the value of Lonza s Ibex ....

Switzerland General , Dirk Oehlers , Jean Christophe Hyvert , Charles Christy , Head Of External Communications , Lonza Group Ltd , Agreement Development Of Sales , Hr Solutions , Lonza Group , Eqs Group , Swiss Exchange , Lonza Group Ag Key , Group News Service , Extends Collaboration , Major Biopharmaceutical Partner , Large Scale Monoclonal Antibody Commercial Supply , Christophe Hyvert , Gene Divisions , Commercial Solutions , Swiss Alps , சார்லஸ் கிறிஸ்டி , தலை ஆஃப் வெளிப்புறம் தகவல்தொடர்புகள் , ர் தீர்வுகள் , ஈக்ஸ் குழு , சுவிஸ் பரிமாற்றம் , குழு செய்தி சேவை ,